Brief news reports on Tuberculosis

Update of WHO guidelines on the programmatic management of drug-resistant TB

End-users (i.e. policy makers; health professionals, including doctors, nurses and educators working in governmental and non-governmental organizations; TB patients) interested in providing comments on the scope of this guideline update are invited to submit their feedback.

Read More →

Thermally-stable TB vaccine closer to reality thanks to microscopic silica cages

Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.

Read More →

Groundbreaking study on KZN community gives new hope to fight TB

Durban - Tuberculosis (TB) despite it being treatable disease is the world's biggest infectious killer, claiming the lives of an estimated 1.6 million people around the world every year including 78 000 South Africans. 

Read More →

Lung lining fluid key to elderly susceptibility to TB infection

Old lungs are not as capable as young lungs of fighting off an infection of the bacteria that causes tuberculosis (TB), placing seniors at a greater risk of developing TB. The microbe that causes this infectious disease, Mycobacterium tuberculosis (Mtb), currently kills more people in the world than any other pathogen.

Read More →

Time to act on the 2018 TB commitments

The Stop TB Partnership, the Global Fund to Fight AIDS, TB and Malaria and the World Health Organization call for immediate action to implement the commitments made by Head of States and Governments at the UN High-Level Meeting on TB.

Read More →

Unmasking the hidden burden of TB in Mozambique

The real burden of tuberculosis (TB) is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital. The study, led by the Barcelona Institute of Global Health (ISGlobal), an institution supported by ”la Caixa”, shows that highly sensible molecular techniques can detect cases that escape clinical diagnosis and even traditional post-mortem examination of organs and tissues.

Read More →

TGen and ABL plan global rollout of advanced test for TB, one of the most deadly pathogens

FLAGSTAFF, Ariz., and LUXEMBOURG CITY, Luxembourg — July 31 — Advanced Biological Laboratories (ABL) is expected to soon begin manufacturing of a compact, portable and affordable test for tuberculosis (TB), designed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

Read More →

How is North Korea coping with TB one year after Global Fund grant cuts?

MANILA — Advocates working to address the tuberculosis burden in North Korea are calling on the Global Fund to Fight AIDS, Tuberculosis and Malaria to resume its grants in the country in the next two months to ensure thousands of patients don’t fall out of treatment. The call comes just a few months before the fund's sixth replenishment conference in October.

Read More →

Tuberculosis is Asia’s silent killer

Tuberculosis (TB), as a Lancet editorial once put it, is an “unsexy” disease. No one dies of it in a matter of days. It’s not highly contagious. It does not come with rashes, haemorrhage, or other dramatic symptoms. And it has been around for so long.

Read More →

New study reveals how TB bacteria may survive in human tissues

Carbon monoxide is an infamous and silent killer that can cause death in minutes. But while it is deadly for us, some microorganisms actually thrive on it, by using this gas as an energy source.

Read More →

Page 1 of 667 · Total posts: 10

1 2 Last→